JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence 
Baseten Secures $1.5 Billion Funding at $13 Billion Valuation Amid AI Infrastructure Boom 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns 
SpaceX Stock Plunges 16% as KeyBanc Warns Valuation May Be Overstretched 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
NEW YORK, Feb. 01, 2016 -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All persons or entities who purchased or otherwise acquired securities of Cnova N.V. (“Cnova”) (NASDAQ:CNV) pursuant and/or traceable to the Initial Public Offering on or about November 19, 2014, and/or between November 19, 2014 and December 18, 2015.
You are hereby notified that a securities class action lawsuit has been commenced in the USDC for the Southern District of New York. If you purchased or otherwise acquired Cnova N.V. securities between November 19, 2014 and December 18, 2015, your rights may be affected by this action. To get more information go to: http://zlk.9nl.com/cnovacnv.
The Complaint alleges that during the Class Period, defendants failed to disclose that Cnova issued misleading financial statements by failing to disclose that the Company lacked adequate internal financial controls and that it had overstated net sales, failed to properly write-off the value of returned items, misstated accounts receivable for damaged/returned items, and overstated EBIT.
If you suffered a loss in Cnova you have until March 21, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/cnovacnv.
Levi & Korsinsky is a national firm with offices in New York, New Jersey, California, Connecticut, and Washington D.C. The firm’s attorneys have extensive expertise and experience representing investors in securities litigation involving financial fraud, and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Levi & Korsinsky, LLP Eduard Korsinsky, Esq. 30 Broad Street - 24th Floor New York, NY 10004 Tel: (212) 363-7500 Toll Free: (877) 363-5972 Fax: (212) 363-7171 www.zlk.com
